4.7 Article

Discovery of Multitarget Inhibitors by Combining Molecular Docking with Common Pharmacophore Matching

Journal

JOURNAL OF MEDICINAL CHEMISTRY
Volume 51, Issue 24, Pages 7882-7888

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/jm8010096

Keywords

-

Funding

  1. Ministry of Science and Technology of China
  2. National Natural Science Foundation of China [90403001, 20773002, 30490245]

Ask authors/readers for more resources

Multitarget drugs have been to be found effective in controlling complex diseases. However, how to design multitarget drugs presents a great challenge. We have developed a computer-assisted strategy to screen for multitarget inhibitors using a combination of molecular docking and common pharmacophore matching. This strategy was successfully applied to screen for dual-target inhibitors against both the human leukotriene A(4) hydrolase (LTA4H-h) and the human nonpancreatic secretory phospholipase A2 (hnps-PLA2). Three compounds screened from the chemical database MDL Available Chemical Directory were found to inhibit these two enzymes at the 10 mu M level. Moreover, one synthetic compound matching the common pharmacophores inhibits LTA4H-h and hnps-PLA2 with IC50 values of 35 nM and 7.3 mu M, respectively. The common pharmacophore model can also be used to search small molecule databases or collections of existing inhibitors, as well as to guide combinatorial library design to search for ideal multitarget inhibitors.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available